RAEB-2

Known as: RAEB-II 
A myelodysplastic syndrome defined by 10-19% blasts in the bone marrow or 5-19% blasts in the blood and <10% blasts in the bone marrow… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2017
051019892017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
A cohort of MDS patients was examined for mutations affecting 4 splice genes (SF3B1, SRSF2, ZRSR2, and U2AF35) and evaluated in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2012
2012
Unlike the case with acute myeloid leukemia, there is limited information on the prognostic impact of isocitrate dehydrogenase… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Prognostic factors for response and survival in higher-risk myelodysplastic syndrome patients treated with azacitidine (AZA… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The World Health Organization (WHO) classification contributes to refined classification and prognostication of myelodysplastic… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We evaluated the impact of World Health Organization (WHO) classification and WHO classification-based Prognostic Scoring System… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE The aim of this study was to evaluate the prognostic value of the WHO proposal, to assess the role of the main prognostic… (More)
Is this relevant?
2002
2002
Treatment with recombinant human erythropoietin (rHuEpo) improves anaemia in approximately 20% of patients with myelodysplastic… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
In current medical practice, patients with refractory anemia with excess blasts in transformation (RAEB-t), and especially… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Previous studies have shown that approximately 40% of patients with myelodysplastic syndrome (MDS) and anaemia respond to… (More)
  • table 1
  • table 2
Is this relevant?
1995
1995
A study was made to determine CR rate, response duration and survival in patients with RAEB or RAEB-t given AML-type chemotherapy… (More)
Is this relevant?